Navigation Links
GenVec Reports Fourth Quarter And 2012 Year-End Financial Results
Date:3/22/2013

ional information about GenVec is available at www.genvec.com and in the Company's various filings with the Securities and Exchange Commission.

Statements herein relating to future financial or business performance, conditions or strategies and other financial and business matters, including expectations regarding funding, grants, collaborations, revenues, cash burn rates, the development of products and the success of the Company's collaborations, including with Novartis and Merial, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act.  GenVec cautions that these forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Factors that may cause actual results to differ materially from the results discussed in the forward-looking statements or historical experience include risks and uncertainties, including the failure by GenVec to secure and maintain relationships with collaborators; risks relating to the early stage of GenVec's product candidates under development; uncertainties relating to research and development activities; risks relating to the commercialization, if any, of GenVec's proposed product candidates; dependence on the efforts of collaborators and third parties; dependence on intellectual property; currently unanticipated expenses, and risks that we may lack the financial resources and access to capital to fund our operations.  Further information on the factors and risks that could affect GenVec's business, financial conditions and results of operations, are contained in GenVec's filings with the U.S. Securities and Exchange Commission (SEC), which are available at www.sec.gov.  These forward-looking statements speak only as of the date of this press release, and GenVec assumes no duty to update forward-looking statements.

(Tables to follow)GenVec
'/>"/>

SOURCE GenVec, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. GenVec To Release First Quarter 2012 Financial Results And Conduct A Conference Call On May 10, 2012
2. GenVec Appoints Cynthia Collins as President and CEO
3. GenVec Reports Inducement Award
4. GenVec Announces Conditional Approval of FMD Vaccine for Cattle
5. GenVec to Release Second Quarter 2012 Financial Results and Conduct a Conference Call on August 9, 2012
6. GenVec Reports Second Quarter 2012 Financial Results
7. GenVec Reports Third Quarter 2012 Financial Results
8. GenVec to Present at 25th Annual ROTH Conference
9. GenVec To Release Fourth Quarter And Year-end 2012 Financial Results And Conduct A Conference Call On March 22, 2013
10. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
11. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... N.Y. , March 30, 2015  A promising ... treatments for patients with a rare and lethal subtype ... recent licensing agreement with a new biotechnology company, Kura ... funding this work, led by Assistant Professor Jolanta ... , Ph.D., at the University of Michigan, since 2009. ...
(Date:3/30/2015)... 30, 2015  Uroplasty, Inc. (NASDAQ: UPI ) ... have voted at the special meeting of each ... announced agreement and plan of merger between the ... the outcome of today,s special meetings, and I ... approving the merger agreement," said Rob Kill ...
(Date:3/30/2015)... March 30, 2015 Perrigo Company plc (NYSE: ... "Quality Affordable Healthcare Products®," today announced that it has ... ("Omega") in a cash and equity transaction valued at ... billion in debt. Sellers are Marc Coucke , ... Waterland.    "The combination of ...
Breaking Medicine Technology:Leukemia Research Funded by The Leukemia & Lymphoma Society Gets Infusion of Support from Startup Biotechnology Company 2Leukemia Research Funded by The Leukemia & Lymphoma Society Gets Infusion of Support from Startup Biotechnology Company 3Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 2Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 3Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 4Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 2Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 3Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 4Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 5
... THE WOODLANDS, Texas, Oct. 12 Lexicon Pharmaceuticals, Inc. ... on discovering breakthrough treatments for human disease, announced today that ... officer, will present at the upcoming BioCentury Newsmakers in the ... 22 at 10:30 a.m. Eastern Time. A live ...
... Md., Oct. 12 The U.S. Food and ... prevent relapse after patients with opioid dependence have ... ) (Logo:   http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) ... naltrexone administered by intramuscular injection once a month. ...
Cached Medicine Technology:Lexicon Pharmaceuticals to Present at BioCentury Newsmakers in the Biotech Industry Conference Oct. 22nd 2FDA Approves Injectable Drug to Treat Opioid-Dependent Patients 2
(Date:3/30/2015)... Murfreesboro, TN (PRWEB) March 30, 2015 Good ... in need. The Children’s Home in Murfreesboro provides a Christian-based ... the love of Christ and his special plan for their ... dawn of a new day begins as, one-by-one, the children ... Samantha’s day begins as the alarm continues to buzz. ...
(Date:3/30/2015)... Murfreesboro, TN (PRWEB) March 30, 2015 Dr. ... TN office. , The mini implant is placed into ... to be stabilized is fitted and snapped into place. For ... or talking, mini implants could be the solution. Thousands of ... right in place without any adhesives. It is all made ...
(Date:3/30/2015)... Dr. Jeffrey Allred DDS, with his practice based ... second opinion consultations for patients who need a second ... second opinions show how small percentage of dentistry patients go ... 6%” – says Dr. Allred. , “People should not ... the dental care provider, for the simple fact that every ...
(Date:3/30/2015)... The partners of Urgent Care of Westchester and ... Bella Diosa Laser Med Spa, offering the residents of ... spa treatments. , February marked the grand opening of ... the medical services provided by Urgent Care of Westchester ... for both women and men. , Conveniently located in ...
(Date:3/30/2015)... The fertility team at Ada ... asked questions to give intended parents across the globe ... , After unveiling the most affordable, non-sharing ... IVF clinic has witnessed an increase in fertility patients. ... provides attentive reproductive care — with all-inclusive IVF treatment ...
Breaking Medicine News(10 mins):Health News:Good Shepherd Children’s Home Announces 53rd Year of Providing a Safe-Haven for Children in Need 2Health News:Dr. Jeffrey Farmer A Murfreesboro Dentist Announces New High Tech Dentistry 2Health News:Allred Dental Offers Complimentary 15 Minute Consults with Dr. Jeffrey Allred in San Marcos, CA 2Health News:Yonkers Celebrates the Grand Opening of Bella Diosa 2Health News:Top Fertility Clinic in Cyprus Answers Key Questions on Egg Donation Process 2Health News:Top Fertility Clinic in Cyprus Answers Key Questions on Egg Donation Process 3Health News:Top Fertility Clinic in Cyprus Answers Key Questions on Egg Donation Process 4
... Ind., Feb. 19 An error in the most ... Yellow Book directed Monroe,Hospital callers to an entirely different ... who expected to schedule their next,appointment instead found they ... to the hotline. , Both ...
... annual report on nation,s health focuses on those aged 18 ... rates of obesity and lack of insurance coverage are among ... just-released statistics. , A special section on young adults between ... annual report on the nation,s health from the U.S. Centers ...
... and surgery is not possible, transplanting stem cells from the patient,s ... this chronic disease. , The procedure has been ... the disease has been shown in 80% of cases, and considerable ... Since August 2008, Hospital Clnic has used this therapy in a ...
... EAST LANSING, Mich. Women are 30 percent less ... than can limit brain damage after a stroke, according ... findings were presented Feb. 19 in San Diego at ... Association and American Stroke Association. , Tissue plasminogen activator, ...
... Nears 187,000 in FebruaryHARRISBURG, Pa., Feb. 19 /PRNewswire-USNewswire/ ... -- also known as CHIP -- has launched ... to better serve Latinos, who are the state,s ... recent study of the uninsured, there are more ...
... 90 Inspected Pennsylvania Facilities Meet Federal StandardsHARRISBURG, Pa., ... released reports today showing that all of the ... quarter of 2008 are operating within the guidelines ... Administration.DEP inspects each of Pennsylvania,s approximately 400 certified ...
Cached Medicine News:Health News:Monroe Hospital: Laughter is Best Medicine for Unwelcome Publicity 2Health News:Obesity, Lack of Insurance Take Toll on Young Americans 2Health News:New therapy with stem cells to treat Crohn's disease 2Health News:New therapy with stem cells to treat Crohn's disease 3Health News:New therapy with stem cells to treat Crohn's disease 4Health News:New therapy with stem cells to treat Crohn's disease 5Health News:Women less likely to receive critical care after a stroke, MSU researchers find 2Health News:CHIP Launches New Web Site Serving Pennsylvania's Fast-Growing Latino Population 2Health News:PA DEP Releases Quarterly Mammography Inspections 2Health News:PA DEP Releases Quarterly Mammography Inspections 3Health News:PA DEP Releases Quarterly Mammography Inspections 4
... Our most popular onsite test! QuickScreen multi-panel ... urine sample, and your choice of any ... multi-panels offer total flexibility for your drug ... the specimen and the built-in timer tells ...
... SureStep™ Drug Screen Tests are available in ... MDMA (Ecstasy). Designed using Microgenics Antibody Technology, ... only point of care immunoassay targeted to ... both MDA and MDEA but no cross-reactivity ...
... The ADC drugs of abuse tests are ... at the SAMHSA recommended cut-off as confirmed by ... result. A more specific alternative method (such as ... a confirmed result. Professional judgment should be applied ...
Accu-Stat Home Drug Test for Marijuana (THC), Cocaine (COC), Amphetamine (AMP), Methamphetamine (mAMP), Opiates (OPI), and Phencyclidine (PCP)....
Medicine Products: